CHIEI GALLO, ALESSANDRA
CHIEI GALLO, ALESSANDRA
Universita' degli Studi di MILANO
Severe Allergic Contact Dermatitis to Hair Dye in a Patient With Atopic Dermatitis During Dupilumab Therapy
2025 A. Chiei Gallo, G. Tavoletti, G. Avallone, E. Bono, F. Barei, P. Calzari, A.V. Marzano, S.M. Ferrucci
Tralokinumab-induced psoriasis relapse in a patient with atopic dermatitis
2025 A. Chiei Gallo, G. Tavoletti, D. Termini, A.V. Marzano, S.M. Ferrucci
Three-year observational study on the long-term efficacy and safety of dupilumab in elderly patients with severe atopic dermatitis
2025 A. Chiei-Gallo, F. Barei, P. Calzari, A. Pisapia, A.V. Marzano, S.M. Ferrucci
Pilot Study on the Effectiveness of Psychological Support in Patients With Chronic Urticaria
2025 E. Iemoli, A. Passerini, F. Barbagelata, C. Baratta, D. Didoni, E. Ticozzi, A. Chiei Gallo, R. Truzoli
Successful treatment of prurigo nodularis with upadacitinib
2025 G. Avallone, A. Bombelli, D. Termini, A. Chiei-Gallo, F. Barei, A.V. Marzano, S.M. Ferrucci
Effectiveness and safety of combined dupilumab and risankizumab in concomitant atopic dermatitis and psoriasis
2025 D. Termini, G. Tavoletti, A. Chiei-Gallo, G. Avallone, F.L. Boggio, A.V. Marzano, S.M. Ferrucci
Effectiveness and Safety of Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis and Previous Failures of Th2 Biologics: A Propensity Score-Matched Study
2025 F. Barei, A. Chiei-Gallo, A. Narcisi, R.C. Ingurgio, P. Malagoli, G. Girolomoni, M. Maurelli, E. Pezzolo, C. Sciarrone, M. Gola, M. Magliulo, P. Savoia, E. Esposto, A.G. Burroni, F. Amoruso, V.G. Bianchi, S.R. Mercuri, F. Satolli, M.B. De Felici Del Giudice, P. Pella, R. Pinto, G. Avallone, C. Gurioli, B.M. Piraccini, A. Balato, E.V. Di Brizzi, R.G. Angileri, F. Manzo Margiotta, M. Romanelli, M. Rossi, M.B. Guanti, G. Lauretta, S. Dastoli, C. Patruno, M. Napolitano, M. Ortoncelli, S. Ribero, A.V. Marzano, S. Ferrucci
Long-term efficacy and safety of dupilumab in adolescents with severe atopic dermatitis: a 3-year real-life study
2025 A. Chiei-Gallo, F. Barei, P. Calzari, A. Pisapia, A.V. Marzano, S.M. Ferrucci
Effectiveness of dupilumab in tralokinumab-resistant patients with atopic dermatitis: A real-world experience from two referral centres
2025 G. Tavoletti, A. Chiei-Gallo, L. Gargiulo, G. Avallone, L. Ibba, F. Barei, P. Calzari, A. Narcisi, A.V. Marzano, S.M. Ferrucci
Effectiveness of dupilumab in the treatment of alopecia areata in patients with concurrent atopic dermatitis: a real-life retrospective study
2024 G. Tavoletti, L. Valtellini, M.A. Mattioli, A. Chiei-Gallo, M. Barbareschi, A.V. Marzano, S.M. Ferrucci
Tralokinumab as a therapeutic option for patients with concurrent atopic dermatitis and alopecia areata
2024 G. Tavoletti, A. Chiei-Gallo, F. Barei, A.V. Marzano, S.M. Ferrucci
Omalizumab for the Treatment of Chronic Spontaneous Urticaria in Adults and Adolescents: An Eight-Year Real-Life Experience
2024 P. Calzari, A. Chiei Gallo, F. Barei, E. Bono, M. Cugno, A.V. Marzano, S.M. Ferrucci
Five-year real-world drug survival of dupilumab in severe atopic dermatitis and associate predictors
2024 F. Barei, P. Calzari, L. Valtellini, A. Chiei Gallo, G. Perego, S. Tavecchio, M. Zussino, A.V. Marzano, S. Ferrucci